Spectrophotometric determination of labetalol in pharmaceutical preparations and spiked human urine.
Two simple and sensitive spectrophotometric methods were developed for the spectrophotometric determination of labetaolol (LBT). Both methods are based on the phenolic nature of the drug. The first method (Method I) is based on coupling LBT with diazotized benzocaine in presence of trimethylamine. A yellow colour peaking at 410 nm was produced and its absorbance is linear with the concentration over the range 1-10 microg ml(-1) with correlation coefficient (n=5) of 0.9993. The molar absorptivity was 2.633 x 10(4) l mol(-1) cm(-1). The second method (Method II) involves coupling LBT with diazotized p-nitroaniline in presence of sodium carbonate. An orange colour peaking at 456 nm was obtained and its absorbance is linear with concentration over the range 1-10 microg ml(-1) with correlation coefficient (n=5) of 0.99935. The stoichiometry of the reaction in both cases was accomplished adopting the limiting logarithmic method and was found to be 1:1. The developed method could be successfully applied to commercial tablets. The results obtained were in good agreement with those obtained using the official methods. No interference was encountered from co-formulated drugs, such as hydrochlorothiazide. The method was further extended to the in-vitro determination of LBT in spiked human urine. The % recovery (n=4) were 97.7+/-5.75 and 103.27+/-5.42 using the Methods I and II, respectively.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, 11451, Riyadh, Saudi Arabia. ffbelal@ksu.edu.sa
F
F
Belal
S
S
Al-Shaboury
A S
AS
Al-Tamra
D000319:Adrenergic beta-Antagonists / Q000032:analysis* / Q000737:chemistry / Q000652:urine; D000814:Aniline Compounds / Q000737:chemistry; D001566:Benzocaine / Q000737:chemistry; D006801:Humans; D007202:Indicators and Reagents; D007741:Labetalol / Q000032:analysis* / Q000737:chemistry / Q000652:urine; D008744:Methylamines / Q000737:chemistry; D015203:Reproducibility of Results; D013053:Spectrophotometry / Q000379:methods; D013607:Tablets
D000319:Adrenergic beta-Antagonists; D000814:Aniline Compounds; D007202:Indicators and Reagents; D008744:Methylamines; D013607:Tablets; C008625:nitroaniline; C023336:trimethylamine; D007741:Labetalol; D001566:Benzocaine